Clicky

Madrigal Pharmaceuticals, Inc.(MDGL) News

Date Title
Nov 15 John Paulson's Strategic Moves in Q3 2024: A Focus on Anglogold Ashanti PLC
Nov 11 Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
Nov 10 1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More
Oct 9 High Growth Tech Stocks To Watch In October 2024
Oct 2 Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference
Oct 1 Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as Senior Vice President, Clinical Development
Sep 30 Madrigal Pharmaceuticals Announces Publication of Positive Health-Related Quality of Life Results from the Phase 3 MAESTRO-NASH Trial of Rezdiffra™ (resmetirom)
Jul 24 Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024
Jul 23 7 Biotech Stocks to Keep on Your Clinical Radar
Jun 12 Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
Jun 10 Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
Jun 6 Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
May 8 Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript
May 8 Madrigal Pharmaceuticals Inc (MDGL) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
May 7 Madrigal Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Rezdiffra Launch
May 7 Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
Apr 24 Madrigal Statement on the Passing of Dr. Stephen Harrison
Apr 23 Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
Apr 15 Latest Insider Selling in April 2024: 10 Stocks to Watch
Apr 9 Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis